PDD vs PTGX · P/E 8.4, rev $61.75B vs rev $269.8M
PDD Holdings Inc. (PDD) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
PDD currently screens at market cap $113.67B and trailing P/E 8.4. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the PDD and PTGX stock pages for the full models.
Not investment advice.